eClinical technologies are becoming more commonplace in drug development as biopharma adopts validated methods to maintain compliance; patient recruitment, engagement and safety; and supply chain forecasting. A growing number of sponsors are adopting a proven electronic technology: Electronic Drug Accountability and Returns Management, or DARM. This white paper illustrates how sponsors are using electronic solutions for Drug Accountability (DA), because they recognize the significant increase in efficiency and accuracy that these methods provide.
To ask questions or provide feedback about this white paper, please use the Request Info button below. Be sure to indicate if you’d like to schedule a follow-up discussion or demo.